Koh Bong Y
SEC-identified person · CIK 1615979 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kalvista Pharmaceuticals, Inc. KALV | Officer | filed 2018 - 2026 |
| Oruka Therapeutics, Inc. ORKA | Officer | filed 2015 - 2025 |
| Tricida, Inc. TCDA | Officer | filed 2022 - 2022 |
| Vistagen Therapeutics, Inc. na | Officer | filed 2022 - 2022 |
| Pharmathene, INC PIP | Officer | filed 2020 - 2021 |
| Unum Therapeutics, Inc. UNUM | Officer | filed 2020 - 2020 |
| Constellation Pharmaceuticals INC CNST | Officer | filed 2019 - 2019 |
| Bellerophon Therapeutics, Inc. BLPH | Officer | filed 2018 - 2019 |
| Shockwave Medical, Inc. SWAV | Officer | filed 2019 - 2019 |
| Avexis, Inc. AVXS | Director | filed 2016 - 2018 |
| Avalanche Biotechnologies, Inc. [AAVL] | Officer | filed 2014 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.